AI-researched · adversarially reviewed · human-checked · corrections public
BEFORE YOU READ — HOW DO YOU RULE?
The Verdict
If you are having a heart attack, a stent can save your life — that is settled and this page is not about it. If you have stable chest pain, three landmark trials across fifteen years keep finding the same thing: stents do not prevent heart attacks or death compared with good medication — and in blinded testing their symptom benefit shrank dramatically. Yet stable patients are still stented at scale, because the procedure pays well and "we opened the blockage" sells itself.
strongSaves lives and heart muscle in heart attacks and unstable angina — emergency stenting is one of modern medicine's genuine triumphs.
moderateRelieves stable angina symptoms faster than medication alone in unblinded comparisons.
moderateLikely provides real symptom relief for stable angina in patients NOT on anti-anginal medication — the blinded ORBITA-2 trial found a genuine (modest) effect there.
§ What it doesn't do
Where the marketing outruns the data
contradictedDoes not prevent heart attacks or death in stable coronary disease, despite how it is routinely sold — COURAGE (2007), ISCHEMIA (2020), and meta-analyses agree.
strongDoes not "fix the plumbing": most future heart attacks arise from plaques that were NOT the tightest blockage on the angiogram. Stenting the visible narrowing does not defuse the artery.
strongIn patients already on good medication, blinded testing (ORBITA, 2017) found the symptom benefit over a placebo procedure was far smaller than everyone assumed.
§ The Money Map
Who profits, stage by stage
The procedureA stent placement bills thousands of dollars (US) and is a major private-hospital revenue line in India. The cath lab is capital equipment that must stay busy.
The reflexCardiologists themselves named it the "oculostenotic reflex": see a narrowing, stent it. The angiogram creates its own demand — every scan is a sales funnel for the procedure that follows.
The incentive gradientThe doctor who recommends the stent is very often the doctor who performs and bills it — a same-visit conflict most patients never register. Documented cases exist of cardiologists doing hundreds of unnecessary stents.
The honest contrastThe alternative — medication + cardiac rehab — pays almost nobody. No device markup, no procedure fee. Guess which one gets the glossy patient brochure.
This pageNo device money, no hospital sponsorship. See "How we make money."
§ The other side
The strongest case against this verdict
The strongest case against our verdict: trials enroll selected, protocol-managed patients, and their "optimal medical therapy" is better than what most real-world patients actually receive and adhere to. For a patient who cannot or will not take four drugs reliably, a one-time mechanical fix has practical value the trials undercount. ISCHEMIA also showed stenting improved symptoms and quality of life for the more symptomatic patients — relief from daily chest pain is not nothing, even if lifespan is unchanged. And revascularization decisions in left-main and severe multivessel disease genuinely differ — the skeptical headline must not leak into the anatomy where intervention still wins.
§ Symmetric harms
Harms of using it — and of avoiding it
If you use it
Procedure risks: bleeding, artery dissection, stroke, kidney injury from contrast — low single-digit percentages, but real, for a procedure that may add nothing.
Dual antiplatelet therapy for months–year after: bleeding risk for the duration.
Stent thrombosis: rare, sudden, and serious — a risk you acquire the moment the metal goes in.
False cure psychology: "I'm fixed" reliably erodes the medication adherence and lifestyle change that actually alter outcomes.
If you avoid it
In a heart attack or unstable symptoms: refusing emergency stenting is potentially fatal. This entire verdict is about STABLE disease.
Refusing the medication arm too — statins, blood-pressure control — abandons the part that actually prevents heart attacks.
Left-main or severe multivessel disease: revascularization (often surgery) has genuine benefit; blanket stent-refusal is as evidence-free as blanket stenting.
§ The Minority Report
Who gets hurt when it goes right for everyone else
The hurt minority here is unusual: it is the MAJORITY of stable patients receiving a procedure that could not help them — plus the small group seriously harmed by it.
Stable, medically-managed patients stented anyway: they absorb 100% of the procedural risk and the bleeding tail of antiplatelet therapy for a benefit trials cannot find.
The ~1–2% with serious procedural complications: for an unnecessary procedure, every one of these harms is fully attributable to the decision, not the disease.
Patients with kidney disease: contrast-induced kidney injury from angiography+PCI they may not have needed.
Anyone whose "blockage" was found by an unnecessary screening angiogram in the first place — the cascade started one test earlier.
How to tell if you might be in this group: Ask one question first: "Am I stable, or is this an emergency?" If stable, ask: "What do COURAGE and ISCHEMIA imply for someone like me — and can we try three months of full medical therapy first?"
§ The alternatives ledger
Everything else, judged by the same standards
strong
Optimal medical therapy (statin, BP control, antianginals, aspirin as indicated) The evidence-backed default for stable disease: same survival as stenting in trials, none of the procedural risk.
strong
Cardiac rehab / structured exercise Almost certainly reduces mortality after cardiac events and improves angina — the most under-prescribed intervention in cardiology, because nobody profits from it.
strong
Bypass surgery (CABG) for specific anatomy For left-main and severe multivessel disease (especially with diabetes), surgery retains genuine outcome benefits. Anatomy decides, not ideology.
none
EECP and chelation-style "artery cleaning" clinics There is no evidence chelation clears arteries; it is the wellness-industry mirror of the stent reflex — a different party profiting from the same plumbing story.
§ The AI Showdown
What other AIs tell you when you ask
We asked each AI the plain question a normal person types: “Do I really need a stent for my chest pain, or can medication work just as well?”
ChatGPT
gpt-5.5 · Oct 11, 2026
7/10
A clinically accurate, well-conditioned answer that lands on the right bottom line and gives strong doctor questions, but it soft-pedals procedural harms and completely skips the financial incentives driving stenting in stable patients.
●●Matches the evidence. It correctly says stents don't reduce heart attack or death in stable disease while remaining clearly beneficial in heart attack, unstable angina and left-main disease, matching the verdict even without naming COURAGE/ISCHEMIA/ORBITA.
●○Names the harms. It flags bleeding from antiplatelet therapy and asks about risks and DAPT duration, but omits the concrete procedural harms (dissection, stroke, contrast kidney injury, stent thrombosis) and the at-risk groups.
○○Follows the money. No mention of procedure reimbursement, the oculostenotic reflex, or the conflict of the same doctor recommending and performing the stent.
●●Honest about uncertainty. It conditions everything on stable vs unstable, notes symptom benefit is faster 'in some people', and avoids naked percentages or false certainty.
●●Useful next step. It gives eight specific cardiologist questions, suggests a second opinion, and includes an emergency red-flag warning without diagnosing or advising any medication change.
Read its full answer
It depends a lot on **why you’re having chest pain** and what tests show. In many people with **stable angina** (predictable chest discomfort with exertion that goes away with rest/nitroglycerin), **medications + lifestyle changes can work as well as a stent for preventing heart attack or death**. A stent is often most helpful for **relieving symptoms** when medications aren’t enough.
But there are situations where a stent or other procedure may be strongly recommended.
## When a stent may be urgent or clearly beneficial
A stent is often needed if you have:
- **Heart attack** or evidence of ongoing heart damage
- **Unstable angina**: chest pain at rest, new/worsening chest pain, or pain that’s increasing in frequency/severity
- A **critical blockage** in certain high-risk locations, such as the **left main coronary artery** or sometimes major proximal arteries
- Severe symptoms despite good medical therapy
- High-risk findings on stress test/imaging or poor heart function related to blocked arteries
## When medication may work just as well
For **stable coronary artery disease**, treatment often starts with “optimal medical therapy,” such as:
- Aspirin or other antiplatelet medicine when appropriate
- High-intensity statin
- Blood pressure control
- Beta blocker, calcium-channel blocker, nitrates, or ranolazine for angina
- Diabetes management if applicable
- Smoking cessation, exercise/cardiac rehab, diet changes
Large studies have found that in many stable patients, stents **do not necessarily reduce future heart attacks or death compared with good medical therapy**, though they can improve angina faster and more noticeably in some people.
## Key questions to ask your cardiologist
Before agreeing to a stent, ask:
1. **Is this stable angina, unstable angina, or a heart attack?**
2. **Which artery is blocked, and by how much?**
3. **Is the blockage in a high-risk location, like the left main artery?**
4. **What did my stress test/CT angiogram/angiogram show?**
5. **Have we tried optimal medical therapy yet? If not, why not?**
6. **What benefit do you expect from the stent—symptom relief, preventing heart attack, or both?**
7. **What are the risks, including bleeding from blood thinners afterward?**
8. **How long would I need dual antiplatelet therapy after the stent?**
## Important safety note
If you’re having chest pain that is **new, severe, happening at rest, lasting more than a few minutes, or associated with shortness of breath, sweating, nausea, fainting, or pain radiating to the arm/jaw/back**, call emergency services now—don’t wait to compare options.
If your symptoms are stable, it’s reasonable to have a detailed discussion with your cardiologist—and even seek a second opinion—about whether medication alone is appropriate for your specific anatomy and risk.
Gemini
gemini-3.5-flash · Oct 11, 2026
5/10
A clear, correctly conditional explanation of the stable-versus-emergency distinction that lands on the right evidence verdict, but it reads like a patient handout — silent on procedural harms, financial incentives, and the blinded-trial caveats.
●●Matches the evidence. It correctly splits emergency from stable disease and states that for stable angina stents don't reduce heart attack or death versus medication, citing COURAGE and ISCHEMIA, though it omits the blinded ORBITA/ORBITA-2 nuance that symptom relief is smaller than assumed in medicated patients.
○○Names the harms. It names no procedural risks (bleeding, dissection, stroke, contrast kidney injury, stent thrombosis, prolonged antiplatelet bleeding) or who is most vulnerable to them.
○○Follows the money. There is no mention of procedure revenue, the oculostenotic reflex, the same-doctor-recommends-and-bills conflict, or trial funding.
●○Honest about uncertainty. It appropriately conditions its answer on stable vs. acute and avoids fake numbers, but presents stent symptom benefit as settled fact and flags no genuine unknowns.
●●Useful next step. It offers four concrete, well-aimed questions for a cardiologist and urges emergency care for acute symptoms without diagnosing or advising any medication change.
Read its full answer
Whether medication can work as well as a stent depends almost entirely on **what type of chest pain you are having** and **how stable your heart condition is**.
Cardiologists broadly separate chest pain into two categories: emergency situations and stable, predictable conditions.
---
### Scenario 1: Emergency Situations (Acute Coronary Syndrome / Heart Attack)
If your chest pain is new, rapidly worsening, or occurring while you are at rest, you may be experiencing an **acute coronary syndrome** (such as a heart attack or unstable angina).
* **Is a stent necessary?** **Yes.** In an emergency, a plaque in your artery has ruptured and formed a blood clot, suddenly cutting off blood flow to the heart muscle.
* **Why?** A stent immediately opens the blocked artery, restores blood flow, saves heart muscle from permanent damage, and is proven to save lives. Medication alone is not sufficient in an emergency setting.
*If you are currently experiencing severe, crushing chest pain, pain spreading to your arm/jaw, shortness of breath, or sweating, seek emergency medical care immediately.*
---
### Scenario 2: Stable Heart Disease (Chronic Stable Angina)
If your chest pain is predictable—for example, it only happens when you exert yourself (like walking up a steep hill) and goes away when you rest or take nitroglycerin—you likely have **stable coronary artery disease**.
For stable chest pain, **medication can often work just as well as a stent.**
* **What the medical research shows:** Major landmark clinical trials (such as the *ISCHEMIA* and *COURAGE* trials) compared patients with stable heart disease who received **Optimal Medical Therapy (OMT)** alone versus those who received medication plus a stent.
* The research showed that for stable disease, **stents do not reduce the long-term risk of heart attack or death** any more than medications do.
* **When medication is the primary treatment:** Doctors often recommend starting with a full regimen of heart medications, combined with lifestyle changes, to protect the heart and reduce symptoms.
* **Why a stent might still be used for stable pain:**
1. **Persistent Symptoms:** If you are taking maximum doses of medication and still having chest pain that limits your quality of life, a stent is very effective at relieving that pain.
2. **High-Risk Blockages:** If an angiogram or scan shows a severe blockage in a critical location (such as the "left main" coronary artery), a stent or bypass surgery may be necessary to prevent complications.
---
### What Does "Optimal Medical Therapy" Involve?
Choosing medication over a stent doesn't mean doing nothing—it means actively treating the underlying heart disease with a combination of drugs designed to protect your arteries and reduce the heart's workload:
* **Plaque Stabilizers & Cholesterol Lowering:** Statins (e.g., atorvastatin) to lower LDL cholesterol and prevent existing plaque from rupturing.
* **Blood Thinners / Antiplatelets:** Daily aspirin or other antiplatelet drugs to prevent blood clots.
* **Symptom & Pressure Management:** Beta-blockers or calcium channel blockers to reduce heart rate and blood pressure, lowering the heart's oxygen demand.
* **Artery Dilators:** Nitrates (like nitroglycerin) to widen blood vessels and improve blood flow during pain episodes.
---
### Questions to Ask Your Cardiologist
To help decide the best path for your specific situation, consider asking your doctor these direct questions:
1. **"Is my chest pain considered stable angina, or am I at immediate risk for a heart attack?"**
2. **"Am I currently on maximum, optimal medical therapy?"**
3. **"If we try adjusting my medications first, how long should we wait to see if my chest pain improves before reconsidering a stent?"**
4. **"Does the location or severity of my blockage make a stent strictly necessary, or is it optional for symptom control?"**
To help me tailor this information, how long have you had this chest pain, and has your doctor mentioned any specific blockages or test results?
Claude
claude-opus-5 · Oct 11, 2026
6/10
Clinically accurate and well-framed on the stable-versus-acute distinction with strong patient questions, but it skips the procedural harms entirely and never touches the financial incentives that drive stenting in stable patients.
●●Matches the evidence. Correctly separates acute from stable disease and states that in stable disease stents treat symptoms rather than prevent heart attacks or death, citing COURAGE, ISCHEMIA and ORBITA-2, though it omits the original blinded ORBITA finding that symptom benefit on background meds was far smaller than assumed.
○○Names the harms. It names no procedural risks at all — no bleeding, dissection, stroke, contrast kidney injury, stent thrombosis, or the months of dual antiplatelet therapy — and does not identify who is most exposed.
○○Follows the money. No mention of procedure revenue, the oculostenotic reflex, the same-doctor-recommends-and-bills conflict, or who funded the trials.
●●Honest about uncertainty. It gives conditional verdicts, lists the exceptions (left main, low EF, refractory symptoms, multivessel/diabetes), flags that 'optimal medical therapy' must be genuinely optimal, and admits it doesn't know the reader's anatomy.
●●Useful next step. It supplies five concrete cardiologist questions (stable vs acute, FFR/iFR, ejection fraction, timeline for reassessment, symptoms vs prevention) and endorses a second opinion without diagnosing or advising any medication change.
Read its full answer
This is one of the most important questions in cardiology, and the honest answer is: **it depends heavily on which situation you're in.**
## The critical distinction
**If this is an acute event** — a heart attack or unstable angina (new, worsening, or at-rest chest pain) — stenting is often life-saving and not really optional. Opening a blocked artery quickly during a STEMI reduces death and permanent heart damage. Medication alone is not equivalent here.
**If this is stable angina** — predictable chest pain that comes with exertion and goes away with rest, present for weeks or months — the evidence is genuinely different, and your question is a very reasonable one.
## What the research shows for stable disease
Several large trials have tested this directly:
- **COURAGE (2007)** and **ISCHEMIA (2020)**, the latter with over 5,000 patients who had moderate-to-severe ischemia on stress testing, both found that an invasive strategy (stents or bypass) did **not** reduce heart attacks or death compared with optimal medical therapy over several years of follow-up.
- **ORBITA-2 (2023)**, a placebo-controlled trial, confirmed that stenting *does* meaningfully reduce angina symptoms in people with significant blockages who aren't on anti-anginal medications.
So the summary most cardiologists would give: in stable disease, stents are primarily a **symptom treatment**, not a life-extender. The reason is that most heart attacks arise from rupture of smaller, non-obstructive plaques elsewhere in the arteries — not from the one tight spot a stent fixes. Medications and risk-factor control treat the whole arterial tree.
## Important exceptions
Revascularization *does* improve survival in specific situations, several of which were excluded from the trials above:
- Significant **left main** coronary artery disease
- **Reduced ejection fraction** / heart failure from ischemia
- Severe symptoms that persist **despite** maximal medical therapy
- Certain multivessel disease patterns (where bypass surgery may beat stenting, particularly in diabetes)
## What "medication alone" actually has to mean
This route only performs as well as the trials suggest if the medical therapy is genuinely optimal — not just a statin and aspirin:
- High-intensity statin, often with ezetimibe or a PCSK9 inhibitor, driving LDL well below 70 mg/dL
- Anti-anginal medication (beta-blocker, calcium channel blocker, long-acting nitrate, sometimes ranolazine)
- Tight blood pressure and diabetes control
- Complete smoking cessation
- **Cardiac rehab / structured exercise** — consistently underused and genuinely effective
- Dietary change
This is harder than having a procedure, which is part of why some people ultimately prefer the stent.
## Questions worth asking your cardiologist
1. Is my situation stable, or acute?
2. Where are the blockages, how severe, and was FFR/iFR (a pressure-wire measurement) used to confirm they're functionally significant?
3. What's my ejection fraction? Is the left main involved?
4. If I try maximal medical therapy first, what's the plan and timeline for reassessing?
5. Is this being recommended for symptoms or to prevent a heart attack?
That last question is especially clarifying — surveys have found many patients believe a stent will prevent a future heart attack when, in stable disease, that's usually not what it does.
**One caveat:** I don't know your anatomy, test results, or symptom pattern, and those details change the answer substantially. If your cardiologist is recommending a stent, it's worth asking them directly how your case fits the ISCHEMIA trial findings — that's a reasonable, informed question, and a good cardiologist will welcome it. If you're unsure, a second opinion for an elective procedure is completely standard.
Each answer is scored blind against this verdict on five public criteria (2 points each): matches the evidence, names the harms, follows the money, honest about uncertainty, useful next step. The scorer is health.ai's pipeline, which runs on Claude — also a contestant here — so the full answers are shown and a person checks every score before it goes live. Think a score is wrong? Challenge it. AI answers change over time; each card shows the date it was asked. See the full leaderboard →
§ Take it to a human
Questions for your doctor
Am I stable? If yes: what happens if we try optimal medication for 3 months first?
Will the doctor recommending this stent also be performing and billing it?
What exactly will this stent change for my risk of heart attack or death — can you show me the trial?
Is my anatomy one of the cases (left-main, multivessel + diabetes) where revascularization genuinely wins?
How well trial-grade medical therapy is replicated in ordinary practice — the strongest pro-stent argument lives in this gap.
Long-term outcomes of the newest stent generations in stable disease (trials lag the hardware).
§ Corrections
Updates & corrections — public, dated, proud
No corrections yet. Found an error? Challenge it — substantiated challenges are corrected within 48 hours and logged here permanently. Submit a challenge →
§ We dissect ourselves too
How WE make money
This pageNo device manufacturers, no hospitals, no cath-lab advertising on this page. Health.AI earns from optional Pro subscriptions. If that changes, this box changes first.
Demand the next dissection
Any disease, drug, supplement, or practice. The queue decides what we dissect next.